Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Norris

Showing results (421-430 of 531) with videos related to

Pageof 54
Sort By:
Angewandte Chemie (International Ed. in English)|June 18, 2015
Small-Molecule-Mediated Degradation of the Androgen Receptor through Hydrophobic TaggingJeffrey L Gustafson, Taavi K Neklesa, Carly S Cox, et al.
Molecular Oncology|March 22, 2016
Glutathione biosynthesis is upregulated at the initiation of MYCN-driven neuroblastoma tumorigenesisDaniel R Carter, Selina K Sutton, Marina Pajic, et al.
Frontiers in Oncology|February 7, 2022
Systematic <i>In Vitro</i> Evaluation of a Library of Approved and Pharmacologically Active Compounds for the Identification of Novel Candidate Drugs for KMT2A-Rearranged LeukemiaMawar Karsa, Emma Ronca, Angelika Bongers, et al.
Leukemia|January 10, 2019
JMJD1C-mediated metabolic dysregulation contributes to HOXA9-dependent leukemogenesisJennifer R Lynch, Basit Salik, Patrick Connerty, et al.
Cancer Research|December 8, 2016
A Myc Activity Signature Predicts Poor Clinical Outcomes in Myc-Associated CancersMoonSun Jung, Amanda J Russell, Bing Liu, et al.
Oncogene|August 24, 2010
TRIM16 acts as a tumour suppressor by inhibitory effects on cytoplasmic vimentin and nuclear E2F1 in neuroblastoma cellsG M Marshall, J L Bell, J Koach, et al.
Biochemical Pharmacology|December 22, 2019
CCI52 sensitizes tumors to 6-mercaptopurine and inhibits MYCN-amplified tumor growthTony Huynh, Jayne Murray, Claudia L Flemming, et al.
Blood|March 21, 2007
Relapse in children with acute lymphoblastic leukemia involving selection of a preexisting drug-resistant subcloneSeoyeon Choi, Michelle J Henderson, Edward Kwan, et al.
European Journal of Cancer (Oxford, England : 1990)|April 24, 2007
Cell lines from MYCN transgenic murine tumours reflect the molecular and biological characteristics of human neuroblastomaAndy J Cheng, Ngan Ching Cheng, Jette Ford, et al.
Oncotarget|April 19, 2014
The histone demethylase JMJD1A induces cell migration and invasion by up-regulating the expression of the long noncoding RNA MALAT1Andrew E Tee, Dora Ling, Charlotte Nelson, et al.
Pageof 54

Showing results (421-430 of 531) with videos related to

Sort By:
Pageof 54
Angewandte Chemie (International Ed. in English)|June 18, 2015
Small-Molecule-Mediated Degradation of the Androgen Receptor through Hydrophobic TaggingJeffrey L Gustafson, Taavi K Neklesa, Carly S Cox, et al.
Molecular Oncology|March 22, 2016
Glutathione biosynthesis is upregulated at the initiation of MYCN-driven neuroblastoma tumorigenesisDaniel R Carter, Selina K Sutton, Marina Pajic, et al.
Frontiers in Oncology|February 7, 2022
Systematic <i>In Vitro</i> Evaluation of a Library of Approved and Pharmacologically Active Compounds for the Identification of Novel Candidate Drugs for KMT2A-Rearranged LeukemiaMawar Karsa, Emma Ronca, Angelika Bongers, et al.
Leukemia|January 10, 2019
JMJD1C-mediated metabolic dysregulation contributes to HOXA9-dependent leukemogenesisJennifer R Lynch, Basit Salik, Patrick Connerty, et al.
Cancer Research|December 8, 2016
A Myc Activity Signature Predicts Poor Clinical Outcomes in Myc-Associated CancersMoonSun Jung, Amanda J Russell, Bing Liu, et al.
Oncogene|August 24, 2010
TRIM16 acts as a tumour suppressor by inhibitory effects on cytoplasmic vimentin and nuclear E2F1 in neuroblastoma cellsG M Marshall, J L Bell, J Koach, et al.
Biochemical Pharmacology|December 22, 2019
CCI52 sensitizes tumors to 6-mercaptopurine and inhibits MYCN-amplified tumor growthTony Huynh, Jayne Murray, Claudia L Flemming, et al.
Blood|March 21, 2007
Relapse in children with acute lymphoblastic leukemia involving selection of a preexisting drug-resistant subcloneSeoyeon Choi, Michelle J Henderson, Edward Kwan, et al.
European Journal of Cancer (Oxford, England : 1990)|April 24, 2007
Cell lines from MYCN transgenic murine tumours reflect the molecular and biological characteristics of human neuroblastomaAndy J Cheng, Ngan Ching Cheng, Jette Ford, et al.
Oncotarget|April 19, 2014
The histone demethylase JMJD1A induces cell migration and invasion by up-regulating the expression of the long noncoding RNA MALAT1Andrew E Tee, Dora Ling, Charlotte Nelson, et al.
Pageof 54